WebApr 13, 2024 · Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced the ... WebApr 10, 2024 · The Dyne Therapeutics, Inc. stock price fell by -4.59% on the last day (Friday, 17th Mar 2024) from $12.85 to $12.26. During the last trading day the stock fluctuated 6.83% from a day low at $12.00 to a day high of $12.82. The price has fallen in 6 of the last 10 days and is down by -18.27% for this period. Volume has increased on the …
DYN Company Profile & Executives - Dyne Therapeutics Inc. - Wall …
WebMar 24, 2024 · Compare with up to 5 Stocks. On Friday 03/24/2024 the closing price of the Dyne Therapeutics Inc Registered Shs share was $11.05 on NAS. Compared to the opening price on Friday 03/24/2024 on NAS ... WebDYN - key executives, insider trading, ownership, revenue and average growth rates. Detailed company description & address for Dyne Therapeutics Inc.. thomas holmes psychology
Silence Therapeutics (SLN) Price To Cash Flow - Zacks.com
WebInsider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note: An FPI is exempt of … WebMar 14, 2024 · Dyne Therapeutics, Inc. Stock Insider Trading. Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 41.593. In total, the insiders bought 3 463 242 and sold 1 329 813 DYN shares in the last 100 trades. WebMar 14, 2024 · Dyne Therapeutics, Inc. Stock Insider Trading. Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 41.593. … ugly glasses men